Global Rare Endocrine Disease Treatment Market Research Report 2023

Report ID: 1992383 | Published Date: Oct 2024 | No. of Page: 92 | Base Year: 2023 | Rating: 3.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Rare Endocrine Disease Treatment Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Biologics
        1.2.3 Organic Compounds
    1.3 Market by Application
        1.3.1 Global Rare Endocrine Disease Treatment Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospital Pharmacies
        1.3.3 Online Pharmacies
        1.3.4 Retail Pharmacies
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Rare Endocrine Disease Treatment Market Perspective (2017-2028)
    2.2 Rare Endocrine Disease Treatment Growth Trends by Region
        2.2.1 Rare Endocrine Disease Treatment Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Rare Endocrine Disease Treatment Historic Market Size by Region (2017-2022)
        2.2.3 Rare Endocrine Disease Treatment Forecasted Market Size by Region (2023-2028)
    2.3 Rare Endocrine Disease Treatment Market Dynamics
        2.3.1 Rare Endocrine Disease Treatment Industry Trends
        2.3.2 Rare Endocrine Disease Treatment Market Drivers
        2.3.3 Rare Endocrine Disease Treatment Market Challenges
        2.3.4 Rare Endocrine Disease Treatment Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Rare Endocrine Disease Treatment Players by Revenue
        3.1.1 Global Top Rare Endocrine Disease Treatment Players by Revenue (2017-2022)
        3.1.2 Global Rare Endocrine Disease Treatment Revenue Market Share by Players (2017-2022)
    3.2 Global Rare Endocrine Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Rare Endocrine Disease Treatment Revenue
    3.4 Global Rare Endocrine Disease Treatment Market Concentration Ratio
        3.4.1 Global Rare Endocrine Disease Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Rare Endocrine Disease Treatment Revenue in 2021
    3.5 Rare Endocrine Disease Treatment Key Players Head office and Area Served
    3.6 Key Players Rare Endocrine Disease Treatment Product Solution and Service
    3.7 Date of Enter into Rare Endocrine Disease Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Rare Endocrine Disease Treatment Breakdown Data by Type
    4.1 Global Rare Endocrine Disease Treatment Historic Market Size by Type (2017-2022)
    4.2 Global Rare Endocrine Disease Treatment Forecasted Market Size by Type (2023-2028)
5 Rare Endocrine Disease Treatment Breakdown Data by Application
    5.1 Global Rare Endocrine Disease Treatment Historic Market Size by Application (2017-2022)
    5.2 Global Rare Endocrine Disease Treatment Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Rare Endocrine Disease Treatment Market Size (2017-2028)
    6.2 North America Rare Endocrine Disease Treatment Market Size by Country (2017-2022)
    6.3 North America Rare Endocrine Disease Treatment Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Rare Endocrine Disease Treatment Market Size (2017-2028)
    7.2 Europe Rare Endocrine Disease Treatment Market Size by Country (2017-2022)
    7.3 Europe Rare Endocrine Disease Treatment Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Rare Endocrine Disease Treatment Market Size (2017-2028)
    8.2 Asia-Pacific Rare Endocrine Disease Treatment Market Size by Country (2017-2022)
    8.3 Asia-Pacific Rare Endocrine Disease Treatment Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Rare Endocrine Disease Treatment Market Size (2017-2028)
    9.2 Latin America Rare Endocrine Disease Treatment Market Size by Country (2017-2022)
    9.3 Latin America Rare Endocrine Disease Treatment Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Rare Endocrine Disease Treatment Market Size (2017-2028)
    10.2 Middle East & Africa Rare Endocrine Disease Treatment Market Size by Country (2017-2022)
    10.3 Middle East & Africa Rare Endocrine Disease Treatment Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Novartis
        11.1.1 Novartis Company Detail
        11.1.2 Novartis Business Overview
        11.1.3 Novartis Rare Endocrine Disease Treatment Introduction
        11.1.4 Novartis Revenue in Rare Endocrine Disease Treatment Business (2017-2022)
        11.1.5 Novartis Recent Development
    11.2 Ipsen
        11.2.1 Ipsen Company Detail
        11.2.2 Ipsen Business Overview
        11.2.3 Ipsen Rare Endocrine Disease Treatment Introduction
        11.2.4 Ipsen Revenue in Rare Endocrine Disease Treatment Business (2017-2022)
        11.2.5 Ipsen Recent Development
    11.3 Pfizer
        11.3.1 Pfizer Company Detail
        11.3.2 Pfizer Business Overview
        11.3.3 Pfizer Rare Endocrine Disease Treatment Introduction
        11.3.4 Pfizer Revenue in Rare Endocrine Disease Treatment Business (2017-2022)
        11.3.5 Pfizer Recent Development
    11.4 Teva
        11.4.1 Teva Company Detail
        11.4.2 Teva Business Overview
        11.4.3 Teva Rare Endocrine Disease Treatment Introduction
        11.4.4 Teva Revenue in Rare Endocrine Disease Treatment Business (2017-2022)
        11.4.5 Teva Recent Development
    11.5 EMD Serono
        11.5.1 EMD Serono Company Detail
        11.5.2 EMD Serono Business Overview
        11.5.3 EMD Serono Rare Endocrine Disease Treatment Introduction
        11.5.4 EMD Serono Revenue in Rare Endocrine Disease Treatment Business (2017-2022)
        11.5.5 EMD Serono Recent Development
    11.6 Novo Nordisk
        11.6.1 Novo Nordisk Company Detail
        11.6.2 Novo Nordisk Business Overview
        11.6.3 Novo Nordisk Rare Endocrine Disease Treatment Introduction
        11.6.4 Novo Nordisk Revenue in Rare Endocrine Disease Treatment Business (2017-2022)
        11.6.5 Novo Nordisk Recent Development
    11.7 Eli Lilly
        11.7.1 Eli Lilly Company Detail
        11.7.2 Eli Lilly Business Overview
        11.7.3 Eli Lilly Rare Endocrine Disease Treatment Introduction
        11.7.4 Eli Lilly Revenue in Rare Endocrine Disease Treatment Business (2017-2022)
        11.7.5 Eli Lilly Recent Development
    11.8 Takeda
        11.8.1 Takeda Company Detail
        11.8.2 Takeda Business Overview
        11.8.3 Takeda Rare Endocrine Disease Treatment Introduction
        11.8.4 Takeda Revenue in Rare Endocrine Disease Treatment Business (2017-2022)
        11.8.5 Takeda Recent Development
    11.9 Amgen
        11.9.1 Amgen Company Detail
        11.9.2 Amgen Business Overview
        11.9.3 Amgen Rare Endocrine Disease Treatment Introduction
        11.9.4 Amgen Revenue in Rare Endocrine Disease Treatment Business (2017-2022)
        11.9.5 Amgen Recent Development
    11.10 Corcept Therapeutics
        11.10.1 Corcept Therapeutics Company Detail
        11.10.2 Corcept Therapeutics Business Overview
        11.10.3 Corcept Therapeutics Rare Endocrine Disease Treatment Introduction
        11.10.4 Corcept Therapeutics Revenue in Rare Endocrine Disease Treatment Business (2017-2022)
        11.10.5 Corcept Therapeutics Recent Development
    11.11 Novelion Therapeutics
        11.11.1 Novelion Therapeutics Company Detail
        11.11.2 Novelion Therapeutics Business Overview
        11.11.3 Novelion Therapeutics Rare Endocrine Disease Treatment Introduction
        11.11.4 Novelion Therapeutics Revenue in Rare Endocrine Disease Treatment Business (2017-2022)
        11.11.5 Novelion Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Rare Endocrine Disease Treatment Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Biologics
    Table 3. Key Players of Organic Compounds
    Table 4. Global Rare Endocrine Disease Treatment Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 5. Global Rare Endocrine Disease Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Rare Endocrine Disease Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Rare Endocrine Disease Treatment Market Share by Region (2017-2022)
    Table 8. Global Rare Endocrine Disease Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Rare Endocrine Disease Treatment Market Share by Region (2023-2028)
    Table 10. Rare Endocrine Disease Treatment Market Trends
    Table 11. Rare Endocrine Disease Treatment Market Drivers
    Table 12. Rare Endocrine Disease Treatment Market Challenges
    Table 13. Rare Endocrine Disease Treatment Market Restraints
    Table 14. Global Rare Endocrine Disease Treatment Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Rare Endocrine Disease Treatment Market Share by Players (2017-2022)
    Table 16. Global Top Rare Endocrine Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rare Endocrine Disease Treatment as of 2021)
    Table 17. Ranking of Global Top Rare Endocrine Disease Treatment Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Rare Endocrine Disease Treatment Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Rare Endocrine Disease Treatment Product Solution and Service
    Table 21. Date of Enter into Rare Endocrine Disease Treatment Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Rare Endocrine Disease Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Rare Endocrine Disease Treatment Revenue Market Share by Type (2017-2022)
    Table 25. Global Rare Endocrine Disease Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Rare Endocrine Disease Treatment Revenue Market Share by Type (2023-2028)
    Table 27. Global Rare Endocrine Disease Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Rare Endocrine Disease Treatment Revenue Market Share by Application (2017-2022)
    Table 29. Global Rare Endocrine Disease Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Rare Endocrine Disease Treatment Revenue Market Share by Application (2023-2028)
    Table 31. North America Rare Endocrine Disease Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 32. North America Rare Endocrine Disease Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 33. Europe Rare Endocrine Disease Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 34. Europe Rare Endocrine Disease Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Asia-Pacific Rare Endocrine Disease Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 36. Asia-Pacific Rare Endocrine Disease Treatment Market Size by Region (2023-2028) & (US$ Million)
    Table 37. Latin America Rare Endocrine Disease Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Latin America Rare Endocrine Disease Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Middle East & Africa Rare Endocrine Disease Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Middle East & Africa Rare Endocrine Disease Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Novartis Company Detail
    Table 42. Novartis Business Overview
    Table 43. Novartis Rare Endocrine Disease Treatment Product
    Table 44. Novartis Revenue in Rare Endocrine Disease Treatment Business (2017-2022) & (US$ Million)
    Table 45. Novartis Recent Development
    Table 46. Ipsen Company Detail
    Table 47. Ipsen Business Overview
    Table 48. Ipsen Rare Endocrine Disease Treatment Product
    Table 49. Ipsen Revenue in Rare Endocrine Disease Treatment Business (2017-2022) & (US$ Million)
    Table 50. Ipsen Recent Development
    Table 51. Pfizer Company Detail
    Table 52. Pfizer Business Overview
    Table 53. Pfizer Rare Endocrine Disease Treatment Product
    Table 54. Pfizer Revenue in Rare Endocrine Disease Treatment Business (2017-2022) & (US$ Million)
    Table 55. Pfizer Recent Development
    Table 56. Teva Company Detail
    Table 57. Teva Business Overview
    Table 58. Teva Rare Endocrine Disease Treatment Product
    Table 59. Teva Revenue in Rare Endocrine Disease Treatment Business (2017-2022) & (US$ Million)
    Table 60. Teva Recent Development
    Table 61. EMD Serono Company Detail
    Table 62. EMD Serono Business Overview
    Table 63. EMD Serono Rare Endocrine Disease Treatment Product
    Table 64. EMD Serono Revenue in Rare Endocrine Disease Treatment Business (2017-2022) & (US$ Million)
    Table 65. EMD Serono Recent Development
    Table 66. Novo Nordisk Company Detail
    Table 67. Novo Nordisk Business Overview
    Table 68. Novo Nordisk Rare Endocrine Disease Treatment Product
    Table 69. Novo Nordisk Revenue in Rare Endocrine Disease Treatment Business (2017-2022) & (US$ Million)
    Table 70. Novo Nordisk Recent Development
    Table 71. Eli Lilly Company Detail
    Table 72. Eli Lilly Business Overview
    Table 73. Eli Lilly Rare Endocrine Disease Treatment Product
    Table 74. Eli Lilly Revenue in Rare Endocrine Disease Treatment Business (2017-2022) & (US$ Million)
    Table 75. Eli Lilly Recent Development
    Table 76. Takeda Company Detail
    Table 77. Takeda Business Overview
    Table 78. Takeda Rare Endocrine Disease Treatment Product
    Table 79. Takeda Revenue in Rare Endocrine Disease Treatment Business (2017-2022) & (US$ Million)
    Table 80. Takeda Recent Development
    Table 81. Amgen Company Detail
    Table 82. Amgen Business Overview
    Table 83. Amgen Rare Endocrine Disease Treatment Product
    Table 84. Amgen Revenue in Rare Endocrine Disease Treatment Business (2017-2022) & (US$ Million)
    Table 85. Amgen Recent Development
    Table 86. Corcept Therapeutics Company Detail
    Table 87. Corcept Therapeutics Business Overview
    Table 88. Corcept Therapeutics Rare Endocrine Disease Treatment Product
    Table 89. Corcept Therapeutics Revenue in Rare Endocrine Disease Treatment Business (2017-2022) & (US$ Million)
    Table 90. Corcept Therapeutics Recent Development
    Table 91. Novelion Therapeutics Company Detail
    Table 92. Novelion Therapeutics Business Overview
    Table 93. Novelion Therapeutics Rare Endocrine Disease TreatmentProduct
    Table 94. Novelion Therapeutics Revenue in Rare Endocrine Disease Treatment Business (2017-2022) & (US$ Million)
    Table 95. Novelion Therapeutics Recent Development
    Table 96. Research Programs/Design for This Report
    Table 97. Key Data Information from Secondary Sources
    Table 98. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Rare Endocrine Disease Treatment Market Share by Type: 2021 VS 2028
    Figure 2. Biologics Features
    Figure 3. Organic Compounds Features
    Figure 4. Global Rare Endocrine Disease Treatment Market Share by Application in 2021 & 2028
    Figure 5. Hospital Pharmacies Case Studies
    Figure 6. Online Pharmacies Case Studies
    Figure 7. Retail Pharmacies Case Studies
    Figure 8. Rare Endocrine Disease Treatment Report Years Considered
    Figure 9. Global Rare Endocrine Disease Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Rare Endocrine Disease Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Rare Endocrine Disease Treatment Market Share by Region: 2021 VS 2028
    Figure 12. Global Rare Endocrine Disease Treatment Market Share by Players in 2021
    Figure 13. Global Top Rare Endocrine Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rare Endocrine Disease Treatment as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Rare Endocrine Disease Treatment Revenue in 2021
    Figure 15. North America Rare Endocrine Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 16. North America Rare Endocrine Disease Treatment Market Share by Country (2017-2028)
    Figure 17. United States Rare Endocrine Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. Canada Rare Endocrine Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Europe Rare Endocrine Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Rare Endocrine Disease Treatment Market Share by Country (2017-2028)
    Figure 21. Germany Rare Endocrine Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. France Rare Endocrine Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. U.K. Rare Endocrine Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Italy Rare Endocrine Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Russia Rare Endocrine Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Nordic Countries Rare Endocrine Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Asia-Pacific Rare Endocrine Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Rare Endocrine Disease Treatment Market Share by Region (2017-2028)
    Figure 29. China Rare Endocrine Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Japan Rare Endocrine Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. South Korea Rare Endocrine Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Southeast Asia Rare Endocrine Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. India Rare Endocrine Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Australia Rare Endocrine Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Latin America Rare Endocrine Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Rare Endocrine Disease Treatment Market Share by Country (2017-2028)
    Figure 37. Mexico Rare Endocrine Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Brazil Rare Endocrine Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Middle East & Africa Rare Endocrine Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Rare Endocrine Disease Treatment Market Share by Country (2017-2028)
    Figure 41. Turkey Rare Endocrine Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Saudi Arabia Rare Endocrine Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Novartis Revenue Growth Rate in Rare Endocrine Disease Treatment Business (2017-2022)
    Figure 44. Ipsen Revenue Growth Rate in Rare Endocrine Disease Treatment Business (2017-2022)
    Figure 45. Pfizer Revenue Growth Rate in Rare Endocrine Disease Treatment Business (2017-2022)
    Figure 46. Teva Revenue Growth Rate in Rare Endocrine Disease Treatment Business (2017-2022)
    Figure 47. EMD Serono Revenue Growth Rate in Rare Endocrine Disease Treatment Business (2017-2022)
    Figure 48. Novo Nordisk Revenue Growth Rate in Rare Endocrine Disease Treatment Business (2017-2022)
    Figure 49. Eli Lilly Revenue Growth Rate in Rare Endocrine Disease Treatment Business (2017-2022)
    Figure 50. Takeda Revenue Growth Rate in Rare Endocrine Disease Treatment Business (2017-2022)
    Figure 51. Amgen Revenue Growth Rate in Rare Endocrine Disease Treatment Business (2017-2022)
    Figure 52. Corcept Therapeutics Revenue Growth Rate in Rare Endocrine Disease Treatment Business (2017-2022)
    Figure 53. Novelion Therapeutics Revenue Growth Rate in Rare Endocrine Disease Treatment Business (2017-2022)
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
    Figure 56. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Novartis
Ipsen
Pfizer
Teva
EMD Serono
Novo Nordisk
Eli Lilly
Takeda
Amgen
Corcept Therapeutics
Novelion Therapeutics
Frequently Asked Questions
Rare Endocrine Disease Treatment report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Rare Endocrine Disease Treatment report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Rare Endocrine Disease Treatment report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports